| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NVAX | Common Stock | Options Exercise | +5,376 | +8.4% | 69,210 | 10 Mar 2024 | Direct | F1 | ||
| transaction | NVAX | Common Stock | Tax liability | $14,154 | -2,597 | -3.8% | $5.45 | 66,613 | 10 Mar 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NVAX | Restricted Stock Units | Options Exercise | $0 | -5,376 | -50% | $0.000000 | 5,376 | 10 Mar 2024 | Common Stock | 5,376 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
| F2 | The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date |